Analyst Ratings for Haemonetics (HAE)
HAE Rating Summary
HAE Price Target Summary
- Highest: $100.00 (Citizens)
- Lowest: $67.00 (Baird)
- Average: $81.25
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$81.25 (+9.5%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 52%
Avg. $ Target:
$81.25 (+9.5%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 52%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/22/2026 | BofA Securities | Craig Bijou | Upgrade | Buy (Neutral) |
80.00 (72.00) |
61.94 (74.17) |
19.74% | Details |
| 12/15/2025 | Needham | Mike Matson | Downgrade | Hold (Buy) |
N/A (N/A) |
83.49 (74.17) |
-11.16% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
